In vitro model of mycobacterial growth arrest using nitric oxide with limited air

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 157-161

  Hussain, Syed ^a   Malik, Muhammad ^a   Shi, Lanbo ^a   Gennaro, Maria Laura ^a   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLENETRIAMINE; GATIFLOXACIN; ISONIAZID; MOXIFLOXACIN; NITRIC OXIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

AERATION; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG STRUCTURE; GROWTH INHIBITION; IN VITRO SELECTION; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

AIR; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; FLUOROQUINOLONES; MYCOBACTERIUM; NITRIC OXIDE DONORS; QUINOLINES; RIFAMPIN; TRIAZENES;

EID: 59749096131     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00442-08     Document Type: Article

References (22)

1. Dong, Y., C. Xu, X. Zhao, J. Domagala, and K. Drlica. 1998. Fluoroquinolone action against mycobacteria: effects of C-8 substituents on bacterial growth, survival, and resistance. Antimicrob. Agents Chemother. 42:2978-2984.
2. Drlica, K., X. Zhao, and B. Kreiswirth. 2008. Minimizing moxifloxacin resistance with tuberculosis. Lancet Infect. Dis. 8:273-275.
3. Hsieh, L.-S., R. M. Burger, and K. Drlica. 1991. Bacterial DNA supercoiling and [ATP]/[ADP]: changes associated with a transition to anaerobic growth. J. Mol. Biol. 219:443-450.
4. Jacobs, W. R., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, R. G. Barletta, and B. R. Bloom. 1991. Genetic systems in mycobacteria. Methods Enzymol. 204:537-555.
5. Koul, A., L. Vranckx, N. Dendouga, W. Balemans, I. VandenWyngaert, K. Vergauwen, H. W. Göhlmann, R. Willebrords, A. Poncelet, J. Guillemont, D. Bald, and K. Andries. 2008. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem. 283:25273-25280.
6. Lillebaek, T., A. Dirksen, I. Baess, B. Strunge, V. Thomsen, and A. Andersen. 2002. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185:401-404.
7. MacMicking, J. D., R. North, R. LaCourse, J. Mudgett, S. Shah, and C. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
8. Malik, M., and K. Drlica. 2006. Moxifloxacin lethality with Mycobacterium tuberculosis in the presence and absence of chloramphenicol. Antimicrob. Agents Chemother. 50:2842-2844.
9. Malik, M., S. Hussain, and K. Drlica. 2007. Effect of anaerobic growth on quinolone lethality with Escherichia coli. Antimicrob. Agents Chemother. 51:28-34.
10. Malik, M., T. Lu, X. Zhao, A. Singh, C. Hattan, J. Domagala, R. Kerns, and K. Drlica. 2005. Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol. Antimicrob. Agents Chemother. 49:2008-2014.
11. Malik, M., X. Zhao, and K. Drlica. 2006. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol. 61:810-825.
12. Miller, B. H., R. Fratti, J. Poschet, G. Timmins, S. Master, M. Burgos, M. Marletta, and V. Deretic. 2004. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect. Immun. 72:2872-2878.
13. Mogues, B. T., M. Goodrich, L. Ryan, R. LaCourse, and R. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
14. Rustomjee, R., C. Lienhardt, T. Kanyok, G. R. Davies, J. Levin, T. Mthiyane, C. Reddy, A. W. Sturm, F. A. Sirgel, J. Allen, D. J. Coleman, B. Fourie, D. A. Mitchison, and the Gatifloxacin for TB (OFLOTUB) study team. 2008. A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 12:128-138.
15. Shi, L., R. North, M. Gennaro, J. Jung, S. Tyagi, and R. J. North. 2004. Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung. Infect. Immun. 72:2420-2424.
16. Shi, L., C. D. Sohaskey, B. Kana, S. Dawes, R. J. North, V. Mizrahi, and M. Gennaro. 2005. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc. Natl. Acad. Sci. USA 102:15629-15634.
17. Vilcheze, C., and W. R. Jacobs. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61:35-50.
18. Voskuil, M., D. Schnappinger, K. Visconti, M. Harrell, G. Dolganov, D. Sherman, and G. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
19. Wayne, L., and G. Diaz. 1967. Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture. J. Bacteriol. 93:1374-1381.
20. Wayne, L., and K. Lin. 1982. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect. Immun. 37:1042-1049.
21. Wayne, L. G. 1994. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13:908-914.
22. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.